Top 5 Articles for Retail Pharmacists in 2022
Pharmacy Times
DECEMBER 26, 2022
This year, retail pharmacists were interested in diabetes research, saving patients money, and influenza vaccine candidates.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Pharmacy Times
DECEMBER 26, 2022
This year, retail pharmacists were interested in diabetes research, saving patients money, and influenza vaccine candidates.
European Pharmaceutical Review
JUNE 27, 2023
AC Immune SA has received Fast Track designation from the US Food and Drug Administration (FDA) for its anti-amyloid beta (Abeta) active immunotherapy vaccine candidate for Alzheimer’s disease. The anti-Abeta therapy “specifically targets the most toxic forms of Abeta” according to Dr Andrea Pfeifer, CEO of AC Immune SA.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Mirror
MAY 31, 2023
In the face of increasing global health challenges, the development and production of vaccines have become paramount. One critical aspect is the ability to scale up manufacturing processes to meet the growing demand for viral vector-based vaccines.
Pharmaceutical Commerce
JANUARY 9, 2024
Review article explores the latest developments surrounding expression and purification strategies.
European Pharmaceutical Review
MAY 12, 2023
A BioNTech-led Phase I trial demonstrated preliminary evidence that adjuvant autogene cevumeran, a personalised mRNA neoantigen vaccine, in combination with atezolizumab (Genentech) and mFOLFIRINOX can induce substantial T cell activity in pancreatic ductal adenocarcinoma (PDAC). Can an mRNA vaccine stimulate T cell response?
Hospital Pharmacy Europe
JUNE 23, 2023
The UK should introduce routine vaccination for respiratory syncytial virus (RSV) to protect babies and older adults, the Joint Committee on Vaccination and Immunisation (JCVI) has recommended. This article was originally published by our sister title Pulse.
Hospital Pharmacy Europe
OCTOBER 12, 2023
Moderna has announced its combined flu and Covid vaccine has generated strong immunogenicity in early-stage trials. Interim results from its phase 1/2 studies found the vaccine (mRNA-1083) generated antibody levels similar to or greater than flu vaccines as well as similar results to the standalone Moderna Covid jab.
pharmaphorum
FEBRUARY 9, 2022
In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector. One area that is gathering increasing levels of interest is the development of cancer vaccines. A broad front.
The People's Pharmacy
JUNE 1, 2023
An ingenious study from Wales suggests that the shingles vaccine can reduce the risk of developing dementia ( MedRxiv, May 25, 2023 ). That said, the idea of using shingles vaccines against dementia is extraordinary. 2, 1933 were ineligible for the Zostavax vaccination to prevent shingles, whereas those born on Sept.
European Pharmaceutical Review
AUGUST 12, 2022
According to researchers, binding nasal vaccine antigens to albumin enables them to bypass mucosal barriers, and could lead to better protection against pathogens like HIV and Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2; the virus that causes COVID-19).
Hospital Pharmacy Europe
NOVEMBER 2, 2023
Pre-conception Covid-19 vaccination has been shown to have no impact on the chance of miscarriage for heterosexual couples. The findings, published in the journal Human Reproduction , suggest that vaccinated couples had a slightly lower rate of miscarriage compared to unvaccinated individuals. The risk dropped to 22.1%
pharmaphorum
JULY 26, 2022
For years, the promise of therapeutic cancer vaccines has intrigued researchers working in the oncology space. Preventative vaccines have already proven to be highly effective against certain cancer types. Preventative vaccines have already proven to be highly effective against certain cancer types. And for good reason.
pharmaphorum
JANUARY 27, 2023
For vaccines that target infectious diseases, as Pragya Khurana and Dr Richard Pitman of ICON explain, cost-effectiveness research can power evidence generation and decision-making that helps keep people safe. Cost-effectiveness modelling is a powerful tool in understanding the value health interventions can bring to populations.
pharmaphorum
MARCH 29, 2022
With the rapid onset of the pandemic, the race to develop a viable vaccine quickly became a race to secure access to the developed vaccines. In this article, Ben Hargreaves examines how wealth determined the winners and what is now underway to help lower-income countries gain access to the available vaccines.
pharmaphorum
JUNE 2, 2021
In the latest edition of What HCPs Think , CREATION.co’s Laura Marsh looks at what healthcare professionals are saying about blood clots linked to COVID-19 vaccines. This sudden increase is due to reports of rare blood clots in recipients of the COVID-19 vaccines developed by AstraZeneca and more recently Johnson & Johnson.
pharmaphorum
JANUARY 20, 2023
For millions of people around the world living with infectious disease and cancer, the arrival of a new prophylactic or therapeutic vaccine on the market can be life changing. Commercialising a vaccine, even one that targets an unmet need, is a challenging task for companies.
pharmaphorum
JANUARY 28, 2022
The failure of the European Commission to locate text messages between its president Ursula von der Leyen and Pfizer chief executive Albert Bourla on procurement of COVID-19 vaccine has earned a rebuke from the EU Ombudsman. billion doses of Pfizer and BioNTech’s vaccine. billion doses of Pfizer and BioNTech’s vaccine.
European Pharmaceutical Review
SEPTEMBER 12, 2023
This article explores common developmental and design issues and how to mitigate difficulties before they occur. The unprecedented success of the COVID-19 vaccine effort, 1 mediated in part by mRNA-based technology, demonstrated that mRNA modalities have immense therapeutic potential.
European Pharmaceutical Review
JUNE 29, 2022
As the healthcare sector grows, there is a clear trend towards the expansion of biologic therapeutic drugs and vaccines like the one developed by Novavax. To summarise, bioproduction hurdles include the necessity to be fast, agile and, not to be understated, able to deliver safe and effective vaccines worldwide. 2021 [cited May 2022].
Pharmaceutical Technology
JULY 22, 2022
Laurie Garrett, a former senior fellow for global health at the Council on Foreign Relations (CFR), shared an article on discussions around Covid-19 being seasonal or a cyclical infection. In addition, immunity against the infection is found to wane for both previously infected individuals and the vaccinated.
Digital Pharmacist
AUGUST 21, 2023
In this article, we’ll delve into a comprehensive breakdown of the past season’s dynamics and provide valuable insights to equip you for the challenges and opportunities that lie ahead. The most effective preventive measure against the flu is getting an annual flu vaccine.
Pharma Tutor
JULY 18, 2022
Historical Overview of Pharmaceutical Industries and Regulatory Affairs:During 1950s, multiple tragedies i.e., sulfanilamide elixir, vaccine tragedy and thalidomide tragedy have resulted in substantial increase of legislations for drug products quality, safety and efficacy. Mon, 07/18/2022 - 15:31.
European Pharmaceutical Review
NOVEMBER 14, 2022
Four medicines recommended for approval in the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP)’s latest meeting included a biosimilar for osteoporosis and a novel COVID-19 vaccine. COVID-19 update. 5 in children five to 11 years. CHMP’s safety update.
European Pharmaceutical Review
NOVEMBER 20, 2023
At the start of November, EPR shared an article exploring how bacterial vaccines could, alongside helping to create more accessible and cost-effective vaccines, be a “key weapon in the fight against AMR”, according to the author, CEO of ReNewVax.
Pharmaceutical Technology
AUGUST 1, 2022
Since 2020, government agencies have provided funding for expensive late-stage vaccine development and the expansion of manufacturing capacity, as well as other key pharmaceutical activities. The shift from private to public funding enabled more rapid development of Covid-19 drugs and vaccines.
The Checkup by Singlecare
APRIL 16, 2024
Avoid live vaccines while taking Stelara. Some examples of live vaccines include the measles, mumps, and rubella (MMR) vaccine, varicella, rotavirus, and nasal flu vaccine. You also should not receive a BCG vaccine (a type of tuberculosis vaccine) while taking Stelara or one year before and after taking Stelara.
The People's Pharmacy
JUNE 15, 2023
.” The Aussies are cautious folks, but in their preliminary report the vaccine match and effectiveness seems promising: “Of the 952 samples referred to the WHOCC in the year-to-date, 96.4% of influenza B/Victoria isolates characterised were antigenically similar to the corresponding vaccine components. What was it like?
pharmaphorum
FEBRUARY 21, 2022
A study of FDA-approved vaccine trials from 2011-2020 showed that 78% of participants were white, even though only 60% of the U.S. Twenty-three percent fewer clinical trials were launched from March through May 2020 because of the pandemic, and many clinical researchers switched to focusing on COVID-19 vaccines and treatments.
Pharmacy Is Right For Me
MAY 1, 2023
For example, some pharmacists offer flu shots and other vaccinations to their patients. —————————————————- This article is an update from a previous article from 2019 , with new contributions thanks to Gayle A. Brazeau, Ph.D.,
IDStewardship
JUNE 12, 2022
Article posted 13 June 2022. There are even journal articles about how to tweet while attending scientific meetings. The frequency of Twitter posts for new research papers mirrors that of news articles, both peaking quickly and hardly mentioned a year later. Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP.
pharmaphorum
MARCH 26, 2021
As chief operating officer, Mullane has supported rapid expansion of the business as it branches into new geographies and business areas including the cell therapy market. • Read the full article in pharmaphorum’s Deep Dive digital magazine.
pharmaphorum
JUNE 1, 2022
In this article, Ben Hargreaves looks at how VR headsets are being used to better educate both healthcare professionals and the general public. In the case of the pandemic, this resulted in vaccine hesitancy in some people, even when they were potentially at risk. The training challenge. In reality. The more you know.
IDStewardship
MAY 12, 2023
In this article five tips for incoming PGY2 pharmacy residents is provided. BCPS, BCIDP Article posted: 12 May 2023 The ASHP pharmacy residency match phases 1 and 2 have come to a close. Core resources can include society guidelines, ACCP Self Assessment Program chapters , review articles, key specialty books (e.g.,
pharmaphorum
APRIL 7, 2021
Oxford University has suspended a clinical trial of its AstraZeneca-partnered COVID-19 vaccine in children and adolescents while a possible link to rare cases of blood clotting is investigated by the UK drugs regulator. . MHRA Chief Executive Dr June Raine reminds everyone to report side effects of Covid-19 vaccine to the #YellowCard scheme.
Pharma Tutor
NOVEMBER 19, 2021
We have also exported more than 65 million doses of COVID vaccines to nearly 100 countries this year. We have exported life-saving medicines and medical equipment to over 150 countries during the initial phase of the pandemic. Fri, 11/19/2021 - 16:19. Pharmapedia.
pharmaphorum
JULY 14, 2022
The European Commission’s failure to reveal text messages between president Ursula von der Leyen and Pfizer chief executive Albert Bourla on COVID-19 vaccine procurement has earned it a formal rebuke from the EU Ombudsman. billion doses of Pfizer and BioNTech’s vaccine. billion doses of Pfizer and BioNTech’s vaccine.
pharmaphorum
JANUARY 12, 2022
If you had been told that within a few months, you’d be living in the middle of the biggest pandemic since the 1918 global flu outbreak, but that thanks to new mRNA technology, vaccine prototypes would be ready for trials within weeks and the first shots would go into arms before the end of 2020, what would you have thought?
The Checkup by Singlecare
MARCH 1, 2024
Live vaccines People who take a steroid, like dexamethasone, should not receive a live or live attenuated vaccine. In some cases, though, getting this vaccine may be okay —for example, if you take a low dose or a short course of steroids. Some examples of live vaccines that are routinely administered in the U.S.
European Pharmaceutical Review
MAY 26, 2023
Read the article on Boehringer Ingelheim’s ILAP designation here. This will help bring innovative new medicines such as cancer vaccines and AI-based therapeutics for mental ill-health to UK patients more quickly. This is a rare tumoural cancer which has not seen new first-line treatment in over forty years.
pharmaphorum
APRIL 12, 2022
Wherever you consider the medical industry, you will find several new technologies being used to make new medicines, vaccines, and fight illnesses. The purpose is to make our lifestyle better and healthier. The last two decades have been revolutionary for the healthcare industry.
Digital Pharmacist
JANUARY 16, 2023
National Influenza Vaccination Week: December 6-12. Cervical Health Awareness Month | S hare downloadable content from the NCCC and advocate for HPV vaccinations. World Immunization Week | Post a flyer and share a list on social media of your vaccination offerings. . National Diabetes Month. COPD Awareness Month.
pharmaphorum
JANUARY 6, 2021
It’s likely no coincidence that Pfizer’s flagship project in 2020 while the design of the logo was being finalised was unquestionably its high-profile alliance with BioNTech on the RNA-based coronavirus vaccine Comirnaty, which provided further evidence of the potential of harnessing genetic toolkits to tackle health issues.
The Checkup by Singlecare
DECEMBER 5, 2022
Read the full article here. Read the full article here. Read the full article here. Read the full article here. Read the full article here. Read the full article here. When untreated, it can lead to health issues such as Type 2 diabetes, obesity, high blood pressure, and high cholesterol. have obesity.
European Pharmaceutical Review
MARCH 27, 2023
” Growing focus on drug and vaccine discovery and development, recent advances in biotechnology and pharmaceutical research and the presence of several US market players offering a wide range of microbial testing products are aiding the growth of the market, the report found. Key market players include bioMerieux SA, Bruker Corp.,
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content